Groowe BETA / Newsroom

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Francois Schramek Promoted to Partner at Manhattan West

prnewswire.com April 13, 2026 at 7:00 AM ET

AI Mentioned as an investment sector for companies Schramek has sourced investments in, not a specific company performance indicator. AMN Mentioned as a venture capital investment sourced by Schramek, indicating potential but not direct stock performance. GM The article mentions 'Space' and 'Defense' as sectors where Schramek has sourced investments, which could include companies like GM involved in these areas, but it's not explicit. LMT The article mentions 'Space' and 'Defense' as sectors where Schramek has sourced investments, which could include companies like Lockheed Martin involved in these areas, but it's not explicit. NVDA The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like NVIDIA, but it's not explicit. GOOG The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Google (Alphabet) involved in AI, but it's not explicit. MSFT The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Microsoft involved in AI, but it's not explicit. SPCE The article mentions 'Space' as a sector where Schramek has sourced investments, which could include companies like Virgin Galactic, but it's not explicit. RKLB The article mentions 'Space' as a sector where Schramek has sourced investments, which could include companies like Rocket Lab, but it's not explicit. GD The article mentions 'Defense' as a sector where Schramek has sourced investments, which could include companies like General Dynamics, but it's not explicit. BA The article mentions 'Defense' as a sector where Schramek has sourced investments, which could include companies like Boeing, but it's not explicit. AMD The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like AMD, but it's not explicit. INTC The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like Intel, but it's not explicit. META The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Meta involved in AI, but it's not explicit. CRWD The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like CrowdStrike, but it's not explicit. PLTR The article mentions 'AI', 'Defense', and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like Palantir, but it's not explicit. AN The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like AutoNation (if they have AI initiatives), but it's not explicit. DD The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like DuPont, but it's not explicit. HON The article mentions 'Space', 'Defense', and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like Honeywell, but it's not explicit. RTX The article mentions 'Space', 'Defense', and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like RTX, but it's not explicit. IBM The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like IBM, but it's not explicit. AMZN The article mentions 'AI' and 'Space' as sectors where Schramek has sourced investments, which could include companies like Amazon (AWS, Blue Origin), but it's not explicit. TSLA The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like Tesla, but it's not explicit. XOM The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like Exxon Mobil (e.g., in energy tech), but it's not explicit. CVX The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like Chevron (e.g., in energy tech), but it's not explicit. UNH The article mentions 'Function Health' as a VC investment, which could be related to healthcare tech companies like UnitedHealth, but it's not explicit. BMY The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Bristol-Myers Squibb, but it's not explicit. PFE The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Pfizer, but it's not explicit. MRK The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Merck, but it's not explicit. JNJ The article mentions 'Function Health' as a VC investment, which could be related to healthcare companies like Johnson & Johnson, but it's not explicit. LLY The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Eli Lilly, but it's not explicit. GILD The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Gilead, but it's not explicit. REGN The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Regeneron, but it's not explicit. BIIB The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Biogen, but it's not explicit. AMGN The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Amgen, but it's not explicit. AZN The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like AstraZeneca, but it's not explicit. NVO The article mentions 'Function Health' as a VC investment, which could be related to biotech/pharma companies like Novo Nordisk, but it's not explicit. SNY The article mentions 'Function Health' as a VC investment, which could be related to pharma companies like Sanofi, but it's not explicit. TEVA The article mentions 'Function Health' as a VC investment, which could be related to generic pharma companies like Teva, but it's not explicit. BABA The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Alibaba, but it's not explicit. JD The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like JD.com, but it's not explicit. NTES The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like NetEase, but it's not explicit. BIDU The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Baidu, but it's not explicit. IQ The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like iQIYI, but it's not explicit. VIPS The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like Vipshop, but it's not explicit. BZUN The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like Baozun, but it's not explicit. HTHT The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Huazhu Group, but it's not explicit. MELI The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like MercadoLibre, but it's not explicit. BBD The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like Brookfield Business Partners, but it's not explicit. BB The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like BlackBerry, but it's not explicit. ERIC The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like Ericsson, but it's not explicit. NOK The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like Nokia, but it's not explicit. QCOM The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like Qualcomm, but it's not explicit. MU The article mentions 'AI' and 'Advanced Tech' as sectors where Schramek has sourced investments, which could include companies like Micron, but it's not explicit. ADSK The article mentions 'Advanced Tech' as a sector where Schramek has sourced investments, which could include companies like Autodesk, but it's not explicit. CRM The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Salesforce, but it's not explicit. GOOGL The article mentions 'AI' as a sector where Schramek has sourced investments, which could include companies like Google (Alphabet) involved in AI, but it's not explicit.

LOS ANGELES, April 13, 2026 /PRNewswire/ -- Francois Schramek, CFA, has been promoted to Partner at Manhattan West, recognizing his significant contributions to the firm's growth, investment leadership, and global client base. Since joining the firm, Schramek has established himself as a trusted advisor to UHNW individuals and family office investors around the world.

Schramek leads a sizable wealth management practice, reflecting the strength and durability of his client relationships. In addition to his direct client work, he maintains close partnerships with hundreds of single and multi-family offices worldwide. His global client relationships span North America, Latin America, Asia, Europe, and the Middle East.

A key member of the firm's investment team, Schramek has led and sourced investments in numerous generational companies across AI, Space, Defense, and Advanced Tech. Over the last two years (as of 4/8/26) Schramek's clients have had access to venture capital investments in Anthropic, Groq, Shield AI, Function Health, AMAN, Epic Games, Zapp, Kalshi, and Polymarket. These investments reflect his forward-looking approach and commitment to identifying transformative businesses at the forefront of innovation.

"Francois' contributions at Manhattan West have been significant," said Lorenzo Esparza, CEO and Founder of Manhattan West. "His ability to combine institutional-quality investment insight with our global clientele has been instrumental in strengthening our platform and expanding our worldwide footprint. His promotion to Partner is both well-earned and reflective of the impact he continues to make."

In his new role as Partner, Schramek will continue to expand the firm's global client relationships, deepen its investment capabilities, and contribute to the strategic direction of Manhattan West. His promotion underscores the firm's commitment to recognizing excellence and investing in leadership that drives long-term value for clients and stakeholders alike.

Media Contact:

Jim McCoy

Chief Operating Officer

[email protected]

SOURCE Manhattan West